Eli Lilly, a large pharmaceutical company, is facing a new legal battle that will determine whether Big Pharma and the FDA can stifle out competition and shut down production of cheaper, generic drugs. The Outsourcing Facilities Association (OFA) has filed a lawsuit against the Food and Drug Administration (FDA) following the agency’s recent decision to […]

www.naturalnews.com